Senestech, Inc. (NASDAQ:SNES – Get Free Report) major shareholder Glenbrook Capital Management purchased 15,390 shares of the business’s stock in a transaction that occurred on Friday, February 13th. The stock was acquired at an average cost of $1.89 per share, with a total value of $29,087.10. Following the completion of the acquisition, the insider directly owned 633,700 shares of the company’s stock, valued at $1,197,693. The trade was a 2.49% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Glenbrook Capital Management also recently made the following trade(s):
- On Thursday, February 12th, Glenbrook Capital Management purchased 7,956 shares of Senestech stock. The shares were bought at an average price of $1.72 per share, for a total transaction of $13,684.32.
- On Wednesday, February 11th, Glenbrook Capital Management acquired 8,000 shares of Senestech stock. The shares were bought at an average cost of $1.73 per share, for a total transaction of $13,840.00.
- On Thursday, February 5th, Glenbrook Capital Management acquired 2,884 shares of Senestech stock. The stock was bought at an average price of $1.77 per share, with a total value of $5,104.68.
- On Wednesday, February 4th, Glenbrook Capital Management bought 5,685 shares of Senestech stock. The stock was bought at an average cost of $1.82 per share, with a total value of $10,346.70.
- On Monday, February 2nd, Glenbrook Capital Management bought 42,739 shares of Senestech stock. The shares were bought at an average price of $1.98 per share, for a total transaction of $84,623.22.
- On Friday, January 30th, Glenbrook Capital Management purchased 5,399 shares of Senestech stock. The shares were bought at an average cost of $1.87 per share, for a total transaction of $10,096.13.
Senestech Price Performance
Shares of Senestech stock traded up $0.22 during midday trading on Friday, reaching $2.00. The company had a trading volume of 44,882 shares, compared to its average volume of 45,234. The company has a current ratio of 15.75, a quick ratio of 14.73 and a debt-to-equity ratio of 0.01. The stock has a fifty day simple moving average of $2.19 and a 200 day simple moving average of $3.44. Senestech, Inc. has a 1-year low of $1.30 and a 1-year high of $6.24. The company has a market capitalization of $10.44 million, a price-to-earnings ratio of -0.55 and a beta of 0.21.
Analysts Set New Price Targets
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Senestech in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Senestech presently has an average rating of “Hold”.
Read Our Latest Stock Report on Senestech
Institutional Trading of Senestech
Institutional investors and hedge funds have recently made changes to their positions in the business. Jane Street Group LLC acquired a new position in Senestech in the fourth quarter valued at about $32,000. Diversify Advisory Services LLC bought a new position in shares of Senestech during the 4th quarter valued at about $34,000. Geode Capital Management LLC acquired a new position in shares of Senestech in the 2nd quarter valued at approximately $59,000. Essex Investment Management Co. LLC acquired a new position in shares of Senestech in the 3rd quarter valued at approximately $115,000. Finally, Millennium Management LLC bought a new stake in Senestech during the 3rd quarter worth approximately $126,000. Institutional investors own 5.19% of the company’s stock.
Senestech Company Profile
SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.
The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.
Read More
- Five stocks we like better than Senestech
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- New gold price target
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
